Chemotherapy of Advanced and Relapsed Squamous Cell Cancer of the Head and Neck with Split-Dose Cisplatinum (DDP), 5-Fluorouracil (Fura) and Leucovorin (CF)
- 52 Downloads
58 patients with locally advanced or relapsed squamous cell heal and neck cancer were treated on 5 consecutive days with DDP 20 mg/m2/d IV-push, followed by CF 100 mg/m2/d IV-bolus and Fura 400 mg/m2/d IV-push 60 minutes later. Treatment was recycled on day 22(−29), according to toxicity. CF was added to the widely used DDP/Fura combination, because recent studies showed enhancement of Fura-activity by CF. 45/58 patients had no prior therapy and 13/58 pts were relapsed after chemotherapy and/or radiation therapy. All patients were evaluable for toxicity and response. After 3 courses of induction chemotherapy 23/45 pts in the previously untreated group had a complete response (CR); 20/45 a partial response(PR), 2/45 were restaged as no change (CR + PR: 95%). Induction chemotherapy was followed by radical surgery and postoperative radiation therapy. In the pretreated group 4/13 pts had a complete response; 6/13 a partial response; no change in 3/13 pts. Median duration of remission (MDR) has not been reached in the primarily untreated group, whereas in pretreated patients the MDR was 3.8 months (range 2.3–11.7 months). Hematologic and gastrointestinal toxicity was substantial but manageable and therapy was performed on an outpatient basis. The combination of DDP, CF and Fura has high activity in untreated and pretreated head and neck cancer patients. The obtained results are comparable to the widely used DDP/Fora continuous infusion regimen.
KeywordsNeck Cancer Induction Chemotherapy Untreated Group Neck Cancer Patient Pretreated Patient
Unable to display preview. Download preview PDF.
- 5.Yin MB, Zakrzewski SF, Hakala MT: Relationship of cellular folate cofactor pools to activity of 5-Fluorouracil. Mol. Pharmacol. 23: 190–197 (1984)Google Scholar
- 8.Scanlon KJ, Nee Dels C, Lu Y, et al: Biochemical basis for Cisplatinum and 5-Fluorouracil synergism in human tumors. Proc. Pm. Assoc. Cancer. Res., 26: 1156 (1986)Google Scholar
- 12.Allegra CJ, Chabner BA, Sholar PW et al: Preliminary results of a phase-II-trial for the treatment of metastatic breast cancer with 5-Fluorouracil and Leucovorin. NCI Monographs, 5: 199–202 (1987)Google Scholar